Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07361562 |
| Title | A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Cogent Biosciences, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| START Midwest | RECRUITING | Grand Rapids | Michigan | 49546 | United States | Details |
| NYU Langone | RECRUITING | New York | New York | 10016 | United States | Details |
| Tennessee Oncology | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| NEXT Oncology Texas | RECRUITING | Austin | Texas | 78758 | United States | Details |
| START Mountain Region | RECRUITING | West Valley City | Utah | 84119 | United States | Details |
| NEXT Oncology Virginia | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |